ENDRA Life Sciences Inc. (NDRA)

USD 6.15

(-14.65%)

Long Term Debt Summary of ENDRA Life Sciences Inc.

  • ENDRA Life Sciences Inc.'s latest annual long term debt in 2023 was 192.06 Thousand USD , down -47.51% from previous year.
  • ENDRA Life Sciences Inc.'s latest quarterly long term debt in 2024 Q1 was 145.82 Thousand USD , down 0.0% from previous quarter.
  • ENDRA Life Sciences Inc. reported annual long term debt of 365.91 Thousand USD in 2022, down -33.06% from previous year.
  • ENDRA Life Sciences Inc. reported annual long term debt of 546.63 Thousand USD in 2021, down -10.24% from previous year.
  • ENDRA Life Sciences Inc. reported quarterly long term debt of 145.82 Thousand USD for 2024 Q1, down 0.0% from previous quarter.
  • ENDRA Life Sciences Inc. reported quarterly long term debt of 237.16 Thousand USD for 2023 Q3, down -15.65% from previous quarter.

Annual Long Term Debt Chart of ENDRA Life Sciences Inc. (2023 - 2014)

Historical Annual Long Term Debt of ENDRA Life Sciences Inc. (2023 - 2014)

Year Long Term Debt Long Term Debt Growth
2023 192.06 Thousand USD -47.51%
2022 365.91 Thousand USD -33.06%
2021 546.63 Thousand USD -10.24%
2020 608.99 Thousand USD 77.65%
2019 342.81 Thousand USD 0.0%
2018 - USD 0.0%
2017 - USD 0.0%
2016 - USD 0.0%
2015 - USD 0.0%
2014 - USD 0.0%

Peer Long Term Debt Comparison of ENDRA Life Sciences Inc.

Name Long Term Debt Long Term Debt Difference
Aclaris Therapeutics, Inc. 3.07 Million USD 93.752%
Applied DNA Sciences, Inc. 739.16 Thousand USD 74.016%
Aspira Women's Health Inc. 1.43 Million USD 86.569%
Biodesix, Inc. 35.22 Million USD 99.455%
BioNexus Gene Lab Corp. 98.76 Thousand USD -94.468%
bioAffinity Technologies, Inc. 1.11 Million USD 82.828%
bioAffinity Technologies, Inc. 1.11 Million USD 82.828%
Bionano Genomics, Inc. 7.17 Million USD 97.323%
CareDx, Inc 28.27 Million USD 99.321%
Check-Cap Ltd. - USD -Infinity%
Castle Biosciences, Inc. 14.19 Million USD 98.647%
DarioHealth Corp. 24.59 Million USD 99.219%
Exact Sciences Corporation 2.47 Billion USD 99.992%
Fulgent Genetics, Inc. 10.11 Million USD 98.1%
Guardant Health, Inc. 1.13 Billion USD 99.983%
ICON Public Limited Company 3.66 Billion USD 99.995%
IDEXX Laboratories, Inc. 622.88 Million USD 99.969%
Illumina, Inc. 1.48 Billion USD 99.987%
Intelligent Bio Solutions Inc. 81.32 Thousand USD -136.169%
iSpecimen Inc. 29.13 Thousand USD -559.327%
Standard BioTools Inc. 3.98 Million USD 95.178%
MDxHealth SA 35.56 Million USD 99.46%
23andMe Holding Co. 67.84 Million USD 99.717%
Medpace Holdings, Inc. 142.12 Million USD 99.865%
Myriad Genetics, Inc. 130.9 Million USD 99.853%
Mainz Biomed B.V. 2.19 Million USD 91.254%
NeoGenomics, Inc. 606.06 Million USD 99.968%
Neogen Corporation 888.39 Million USD 99.978%
Inotiv, Inc. 399.4 Million USD 99.952%
Natera, Inc. 282.94 Million USD 99.932%
OPKO Health, Inc. 222.03 Million USD 99.913%
Psychemedics Corporation 945 Thousand USD 79.676%
Prenetics Global Limited 867.21 Thousand USD 77.853%
Prenetics Global Limited 867.21 Thousand USD 77.853%
Precipio, Inc. 106 Thousand USD -81.191%
Personalis, Inc. 1.23 Million USD 84.436%
RadNet, Inc. 812.06 Million USD 99.976%
Sera Prognostics, Inc. 840 Thousand USD 77.135%
Sotera Health Company 2.22 Billion USD 99.991%
Neuronetics, Inc. 59.28 Million USD 99.676%
Star Equity Holdings, Inc. 1.14 Million USD 83.226%
Star Equity Holdings, Inc. 1.14 Million USD 83.226%
Trinity Biotech plc 54.65 Million USD 99.649%
Twist Bioscience Corporation 79.17 Million USD 99.757%
Exagen Inc. 19.23 Million USD 99.001%